Option 1: Entry Clone Construction (BP Reaction)
We synthesize your GoI and clone it into a pDONR Vector (attP x attB -> attL flanked Entry Clone). Ideal starting point.
The Gateway Cloning System is a highly efficient, high-throughput molecular biology platform developed by Invitrogen (now Thermo Fisher). It allows researchers to seamlessly transfer a gene of interest (GoI) from a universal Entry Clone into multiple, functionally diverse Destination Vectors without using restriction enzymes or ligase. This site-specific recombination technology enables rapid screening of expression systems in various host organisms (e.g., bacterial, yeast, mammalian, plant) and under different regulatory controls (e.g., inducible, constitutive).
CD Biosynsis offers a comprehensive Gateway Cloning Service designed to accelerate your functional studies. We handle the entire process, from synthesizing your GoI and constructing the initial Entry Clone (attL flanked) to performing the final LR and BP recombination reactions into any standard or custom Destination Vector. Our automated, high-fidelity platform guarantees successful production of sequence-verified Expression Clones for rapid and parallel functional analysis.
Get a QuoteKey advantages of using our high-throughput Gateway Cloning platform:
Gateway Cloning is essential for large-scale, functional genomics projects and protein expression screening:
Protein Expression Screening
Rapidly transferring a GoI into multiple Destination Vectors (e.g., with different tags or promoters) to find the optimal expression system.
Functional Genomics & cDNA Libraries
High-throughput cloning of entire cDNA libraries into an Entry Clone collection for eventual rapid transfer to functional assay vectors.
Dual-Hybridization Systems
Efficiently cloning interacting proteins into Destination Vectors for Yeast Two-Hybrid or mammalian Protein-Protein Interaction studies.
Protein Tagging & Localization
Seamlessly fusing GoIs with various N or C-terminal GFP, His-tag, Flag-tag or purification tags using compatible Destination Vectors.
We provide flexible options to enter the Gateway workflow at any stage:
Option 1: Entry Clone Construction (BP Reaction)
We synthesize your GoI and clone it into a pDONR Vector (attP x attB -> attL flanked Entry Clone). Ideal starting point.
Option 2: Expression Clone Generation (LR Reaction)
Using a client-provided or internal Entry Clone, we perform the LR reaction into your specified Destination Vector (attL x attR -> attB).
Option 3: Multi-Fragment Assembly (MultiSite)
Cloning of two or more Entry Clones (e.g., Promoter, GoI, Tag) simultaneously into a MultiSite Destination Vector.
Destination Vector Customization
We can adapt your existing proprietary vector to be Gateway-compatible by inserting the necessary attR recombination sites and ccdB selection cassette.
High-Throughput Cloning Arrays
Automated parallel LR reactions for transferring dozens to hundreds of Entry Clones into one or more Destination Vectors in 96-well format.
Our integrated workflow ensures high-yield, sequence-verified Gateway clones:
We provide the assurance needed for multi-vector expression screening:
What are attB and attL sites?
They are the core DNA sequences recognized by the Gateway recombinase enzymes. attB and attP sites are used in the BP reaction to create the Entry Clone with attL sites; attL and attR sites are used in the LR reaction to create the final Expression Clone with attB sites.
Is Gateway cloning reversible?
Yes. The BP reaction (creating the Entry Clone) and the LR reaction (creating the Expression Clone) are freely reversible using the BP and LR Clonase mixes, respectively. This allows for recovery or reuse of the fragments.
How do you ensure correct reading frame fusion with tags?
We perform Frame Check during the Entry Clone design phase. By analyzing the att site structure and the Destination Vector sequence, we ensure the GoI is precisely inserted in-frame with any N or C-terminal fusion tags present in the Destination Vector.
Can I use my own Destination Vectors?
Yes. If your vector is already Gateway-adapted (attR sites and ccdB gene), we accept it. If not, we can provide a service to modify your custom vector to be Gateway-compatible.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.